Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sangamo Therapeutics Inc

0.7468
+0.04666.66%
Pre-market: 0.5059-0.2409-32.26%05:25 EDT
Volume:7.90M
Turnover:5.73M
Market Cap:167.81M
PE:-1.54
High:0.7624
Open:0.6897
Low:0.6874
Close:0.7002
Loading ...

Sangamo Therapeutics Inc - Isaralgagene Civaparvovec Generally Well-Tolerated With Most Adverse Events Grade 1-2

THOMSON REUTERS
·
06 Feb

Sangamo Therapeutics Announces Updated Phase 1/2 STAAR Study Data in Fabry Disease Showing Sustained Benefit, Improvements in Kidney Function and Favorable Safety Profile

THOMSON REUTERS
·
06 Feb

Sangamo Therapeutics Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
27 Jan

Sangamo Therapeutics Is Maintained at Buy by Truist Securities

Dow Jones
·
24 Jan

Truist Financial Keeps Their Buy Rating on Sangamo Biosciences (SGMO)

TIPRANKS
·
23 Jan

Sangamo Therapeutics Inc. (SGMO): This Small-Cap Stock Is Poised To Outperform in 2025

Insider Monkey
·
08 Jan

Pharma Stock Roundup: PFE Ends Hemophilia Deal With SGMO & More

Zacks
·
03 Jan

Sangamo Therapeutics Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
02 Jan

Company News for Jan 2, 2025

Zacks
·
02 Jan

Post-Bell | Wall Street Ends Lower; Nvidia and Palantir Drop 2%; Tesla Declines 3%; MicroStrategy Sinks 4%

Tiger Newspress
·
01 Jan

US Equities Markets End Lower Tuesday In Last Trading Session of 2024

MT Newswires Live
·
01 Jan

Equity Markets Fall Intraday as 2024 Draws to Close

MT Newswires
·
01 Jan

Sector Update: Health Care Stocks Lower in Afternoon Trading

MT Newswires Live
·
01 Jan

US Equity Indexes Decline After Midday Tuesday as 2024 Draws to Close

MT Newswires Live
·
01 Jan

Top Stock Movers Now: Moderna, Verisign, Dave, and More

Investopedia
·
01 Jan

Top Midday Stories: Sangamo Shares Fall After Pfizer Exits Collaboration; Dave Denies DOJ Allegations

MT Newswires Live
·
01 Jan

Sangamo Therapeutics' stock falls the most in 16 years after Pfizer ends Hemophilia pact

Dow Jones
·
01 Jan

Sangamo selloff on Pfizer decision overdone, says H.C. Wainwright

TIPRANKS
·
01 Jan

Pfizer Exit Sends Sangamo Plummeting 50%, Casting Doubt on Hemophilia Gene Therapy's Future

GuruFocus.com
·
01 Jan

Sangamo price target lowered to $3 from $7 at Jefferies

TIPRANKS
·
01 Jan